{"chunk_id": "medquad__chunk_47944", "source": "medquad", "text": "eed for insulin and improve blood glucose control in some people with acromegaly who already have diabetes.\n                \nThe second medication group is the GH receptor antagonists (GHRAs), which interfere with the action of GH. They normalize IGF-I levels in more than 90 percent of patients. They do not, however, lower GH levels. Given once a day through injection, GHRAs are usually well-tolerated by patients. The long-term effects of these drugs on tumor growth are still under study. Side e"}